SCHEMBL3099816

SCHEMBL3099816

C1CCC(C2OCCO2)CC1

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5704247 1.00 ALDH1A1 (0.41) ALDH1A1
SCHEMBL21579078 1.00 ALDH1A1 (0.41) ALDH1A1
SCHEMBL1560004 0.97 ALDH1A1 (0.44) ALDH1A1
SCHEMBL11846484 0.91 ALDH1A1 (0.39) ALDH1A1
SCHEMBL3981276 0.91 ALDH1A1 (0.39) ALDH1A1
SCHEMBL11854666 0.91 ALDH1A1 (0.39) ALDH1A1
SCHEMBL9426816 0.91 ALDH1A1 (0.39) ALDH1A1
SCHEMBL15572079 0.90
SCHEMBL10524202 0.88 ALDH1A1 (0.41) ALDH1A1
SCHEMBL16016150 0.86 ALDH1A1 (0.35) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4304921-A Method of preparing β-halo esters from cyclic acetals VANDERBILT UNIVERSITY (US) 1981-12-08 US claimed
US-11820781-B2 Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway NURIX THERAPEUTICS, INC. (US) 2023-11-21 US disclosed
CN-116082289-A 4-R-phenylcyclohexyl formaldehyde ethylene glycol and preparation method thereof 河北凡克新材料有限公司 2023-05-09 CN disclosed
CN-110536875-A Interlayer film for laminated glass and laminated glass SEKISUI CHEMICAL CO LTD 2019-12-03 CN disclosed
CN-105492477-B Actinic energy ray curable resion composition and solidfied material 三洋化成工业株式会社 2018-11-20 CN disclosed
CN-108624139-A Radiation-curing type inkjet compositions and ink jet recording method 精工爱普生株式会社 2018-10-09 CN disclosed
CN-108026225-A Resin composition for mold material, resin composition for support material, stereolithography article, and method for producing stereolithography article 麦克赛尔控股株式会社 2018-05-11 CN disclosed
US-9637473-B2 Acrylamide derivatives as antimalarial agents ACTELION PHARMACEUTICALS LTD. (CH) 2017-05-02 US disclosed
US-20160024050-A1 NOVEL ACRYLAMIDE DERIVATIVES AS ANTIMALARIAL AGENTS ACTELION PHARMACEUTICALS LTD (CH) 2016-01-28 US disclosed
CN-103717690-B multilayer pressure-sensitive adhesive film 3M INNOVATIVE PROPERTIES CO. (US) 2016-01-13 CN disclosed
US-8227645-B2 Cyclisation process of forming a multiple ring compound NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-07-24 US disclosed
US-20120101082-A1 VASOPRESSIN V1A ANTAGONISTS BATT ANDRZEJ ROMAN (GB) 2012-04-26 US disclosed
US-20100228058-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2010-09-09 US disclosed
US-7282316-B2 Sulfonyldiazomethane compounds, photoacid generator, resist materials and patterning using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-10-16 US disclosed
WO-2007097719-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2007-08-30 WO disclosed
US-7071362-B2 Process for producing alicyclic aldehydes MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-07-04 US disclosed
US-20050054879-A1 Process for producing alicyclic aldehydes MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2005-03-10 US disclosed
US-20050048395-A1 Novel sulfonyldiazomethane compounds, photoacid generator, resist materials and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. 2005-03-03 US disclosed
EP-1510512-A1 Process for producing alicyclic aldehydes MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2005-03-02 EP disclosed
US-4304921-A Method of preparing β-halo esters from cyclic acetals VANDERBILT UNIVERSITY (US) 1981-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100228058-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND DHPS, GGPS1, COASY ALDH1A1 1419/4885
US-11820781-B2 Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway BTK, CBL, XIAP ALDH1A1 4172/4885
US-20120101082-A1 VASOPRESSIN V1A ANTAGONISTS AVPR1A, AVPR2, AVPR1B ALDH1A1 902/4885
US-20160024050-A1 NOVEL ACRYLAMIDE DERIVATIVES AS ANTIMALARIAL AGENTS RECQL, ACR, ABCC3 ALDH1A1 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.